184 related articles for article (PubMed ID: 15679766)
21. First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens.
Koivisto TT; Rautelin HI; Voutilainen ME; Heikkinen MT; Koskenpato JP; Färkkilä MA
Aliment Pharmacol Ther; 2005 Mar; 21(6):773-82. PubMed ID: 15771764
[TBL] [Abstract][Full Text] [Related]
22. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori.
Borody TJ; Brandl S; Andrews P; Ferch N; Jankiewicz E; Hyland L
Am J Gastroenterol; 1994 Jan; 89(1):33-8. PubMed ID: 8273794
[TBL] [Abstract][Full Text] [Related]
23. Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure.
Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
Helicobacter; 2007 Feb; 12(1):68-73. PubMed ID: 17241304
[TBL] [Abstract][Full Text] [Related]
24. Eradication of Helicobacter pylori infection after ranitidine bismuth citrate, metronidazole and tetracycline for 7 or 10 days.
Knigge K; Kelly C; Peterson WL; Fennerty MB
Aliment Pharmacol Ther; 1999 Mar; 13(3):323-6. PubMed ID: 10102965
[TBL] [Abstract][Full Text] [Related]
25. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
Akyildiz M; Akay S; Musoglu A; Tuncyurek M; Aydin A
Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093
[TBL] [Abstract][Full Text] [Related]
27. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
Tam YH; Yeung CK; Lee KH
Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
[TBL] [Abstract][Full Text] [Related]
28. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study.
Katelaris PH; Forbes GM; Talley NJ; Crotty B
Gastroenterology; 2002 Dec; 123(6):1763-9. PubMed ID: 12454831
[TBL] [Abstract][Full Text] [Related]
29. Second-line Helicobacter pylori eradication: a randomized comparison of 1-week or 2-week bismuth-containing quadruple therapy.
Chung JW; Lee JH; Jung HY; Yun SC; Oh TH; Choi KD; Song HJ; Lee GH; Kim JH
Helicobacter; 2011 Aug; 16(4):289-94. PubMed ID: 21762268
[TBL] [Abstract][Full Text] [Related]
30. Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection.
de Boer WA
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):697-700. PubMed ID: 10445785
[TBL] [Abstract][Full Text] [Related]
31. The influence of pretreatment on cure rates of Helicobacter pylori eradication.
Janssen MJ; Laheij RJ; Jansen JB; de Boer WA
Neth J Med; 2004 Jun; 62(6):192-6. PubMed ID: 15460498
[TBL] [Abstract][Full Text] [Related]
32. Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori.
Delchier JC; Malfertheiner P; Thieroff-Ekerdt R
Aliment Pharmacol Ther; 2014 Jul; 40(2):171-7. PubMed ID: 24863854
[TBL] [Abstract][Full Text] [Related]
33. Pylera plus omeprazole: quadruple treatment for Helicobacter pylori.
Baker DE
Rev Gastroenterol Disord; 2008; 8(1):33-41. PubMed ID: 18477968
[TBL] [Abstract][Full Text] [Related]
34. Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.
al-Assi MT; Genta RM; Karttunen TJ; Cole RA; Graham DY
Am J Gastroenterol; 1995 Mar; 90(3):403-5. PubMed ID: 7872278
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study.
O'Morain C; Borody T; Farley A; De Boer WA; Dallaire C; Schuman R; Piotrowski J; Fallone CA; Tytgat G; Mégraud F; Spénard J;
Aliment Pharmacol Ther; 2003 Feb; 17(3):415-20. PubMed ID: 12562455
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone.
Nijevitch AA; Shcherbakov PL; Sataev VU; Khasanov RSh; Al Khashash R; Tuygunov MM
Aliment Pharmacol Ther; 2005 Nov; 22(9):881-7. PubMed ID: 16225499
[TBL] [Abstract][Full Text] [Related]
37. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
[No Abstract] [Full Text] [Related]
38. Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial.
Nguyen TV; Bengtsson C; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
Helicobacter; 2008 Dec; 13(6):550-6. PubMed ID: 19166421
[TBL] [Abstract][Full Text] [Related]
39. Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection.
Matsushima M; Suzuki T; Kurumada T; Watanabe S; Watanabe K; Kobayashi K; Deguchi R; Masui A; Takagi A; Shirai T; Muraoka H; Kobayashi I; Mine T
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):232-6. PubMed ID: 16460479
[TBL] [Abstract][Full Text] [Related]
40. Triple therapy and Helicobacter pylori.
Davis S
Aust Fam Physician; 1996 Jan; 25(1):53, 56-9. PubMed ID: 8607776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
